This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Thyrogen

Sanofi

Drug Names(s): thyrotropin alpha, thyroid stimulating hormone

Description: Thyrogen is recombinant human thyroid stimulating hormone. It is an adjunctive diagnostic agent used in the follow-up of patients with well-differentiated thyroid cancer. It was developed by Genzyme General to allow patients to continue taking their thyroid hormone supplements while they are being screened for residual or recurring thyroid cancer, which helps patients avoid the debilitating effects of hypothyroidism.

Deal Structure: Biobras S.A. exclusively distributes and markets Thyrogen in Brazil.

In December 2009, Genzyme and Hospira entered into an agreement for Hospira to perform fill and finish manufacturing services for Genzyme's products Cerezyme, Fabrazyme, Myozyme and Thyrogen.

In June 2010, Genzyme and Hospira entered into an agreement for Hospira to perform fill and finish manufacturing services for Genzyme's products, including Cerezyme, Fabrazyme, Myozyme, Lumizyme, Thyrogen, Thymoglobulin, Campath and certain of Genzyme's product candidates in development. This agreement replaces prior agreements between Genzyme and Hospira regarding fill and finish services, including the Technology Transfer and Supply Agreement dated as of December 31, 2009.

In October 2010, Sanofi-aventis announced it has commenced a tender offer for all outstanding shares of common stock of Genzyme for $69 per share, net to the seller in cash, without interest and less any required withholding taxes. In April 2011,...See full deal structure in Biomedtracker


Thyrogen News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug